Special Advertising

Lpath Inc. (LPTN) Stock Quote

Detailed Quote for Lpath Inc. (LPTN)
$ 3.22   0.08 (+2.55%) Volume: 35.46k 4:00 PM EDT Aug 22, 2014
Today 5d 1m 3m 1y more
Last Price
3.22
Change $
0.08
Change %
2.55%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
3.17
High
3.24
Low
3.05
Prev Close
3.14
Last Trade
08/22/14
Volume
35.46k
52 Wk Hi
6.46
52 Wk Low
2.75
Market Cap
50.29m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
15,618,666
EPS (TTM)
-0.75
PE Ratio
N/A
Exchange
NSC
News and Media for Lpath Inc. (LPTN)
Sector News | Topic News
News for Lpath Inc. (LPTN)
Tue, Aug 19, 2014
10:13 AM Lpath Inc. reaches new 52-week Low - QuoteMedia
Mon, Aug 18, 2014
11:27 AM Lpath Inc. reaches new 52-week Low - QuoteMedia
Mon, Aug 11, 2014
8:00 AM Lpath to Present at 34th Annual Canaccord Genuity Growth Conference - PR Newswire
Thu, Jul 24, 2014
8:00 AM Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP - PR Newswire
Thu, Jul 17, 2014
9:51 AM Lpath Inc. reaches new 52-week Low - QuoteMedia
Wed, Jul 16, 2014
9:58 AM Lpath Inc. reaches new 52-week Low - QuoteMedia
Fri, Jul 11, 2014
10:15 AM Lpath Inc. reaches new 52-week Low - QuoteMedia
Mon, Jun 02, 2014
8:00 AM Lpath to Present Trial-in-Progress Poster at ASCO Describing the ASONEP Phase 2 Clinical Trial in RCC Patients - PR Newswire
Tue, May 27, 2014
9:52 PM Is Lpath Inc. a Savior from Blindness? - Equities.com
Mon, May 05, 2014
7:30 AM Lpath Lands Fast-Track SBIR Grant from the NIH for Traumatic Brain Injury Treatment - PR Newswire
Wed, Apr 23, 2014
7:30 AM Lpath and Walter Reed Army Institute for Research Begin Efficacy Study Using Lpathomab in Traumatic Brain Injury Models - PR Newswire
Wed, Mar 05, 2014
7:30 AM New Published Paper Shows Efficacy of Lpath's Anti-LPA Antibody, Lpathomab, in Traumatic Brain Injury Models - PR Newswire
Tue, Mar 04, 2014
8:00 AM Lpath to Present at Upcoming Roth Investor Conference - PR Newswire
Thu, Oct 17, 2013
8:52 AM Five Star Equities Issues New Research Reports on ARIA, CGIX, CYTR and LPTN - Accesswire
Thu, Mar 01, 2012
7:19 AM Keeping an eye on Lpath as shares look to build momentum - Accesswire
Tue, Dec 06, 2011
11:13 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
11:06 AM Set to move: Three micro-cap stocks that analysts and instituional investors like - Accesswire
Thu, Dec 01, 2011
2:11 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
2:10 PM Lipid Signaling program makes Lpath Inc. intriguing to Big Pharma - Accesswire
More News for LPTN >>

Tags for Lpath Inc.

Research stocks or mutual funds related to Lpath Inc. by keywords or tags. Find companies that have a similar focus to LPTN. The keywords below have been associated to LPTN by either user submission or electronic means.

microcurrent macular degeneration clinical trials database human monoclonal antibody clinical research trial clinical development clinical cost antibody protein clinical pharmacology cv therapeutics stock clinical research consulting outsourcing clinical trials angiogenesis inhibitors Biological Products corporate governance clinical investigators cra clinical research cv therapeutics clinical research clinical research investigators board of directors role clinical trials manager board of directors governance board compensation antibodies directors duties board governance human antibodies Drugs monospecific antibodies pain therapeutics cardiology clinical trials clinical trials conference board of directors info medical device clinical trial cedra clinical research board of directors compensation board of directors responsibility cellegy pharmaceuticals international clinical trials board responsibilities clinical data medical trials monoclonal antibody Healthcare corporate governance board of directors monitoring clinical research clinical research guidelines clinical outsourcing clinical research investigator monospecific antibody